Iambic Therapeutics
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.

Hippocratic AI builds a safety-focused clinical voice AI platform for health systems, payors, and life sciences organizations. It supports patient outreach, care management, and other clinical workflows across more than 1,000 use cases.
Hippocratic AI provides a safety-focused clinical voice AI platform for health systems, payors, and life sciences organizations. The company positions its technology as the safest clinical voice AI for healthcare, and it has been used in more than 180 million clinical interactions across over 1,000 use cases with more than 60 partners worldwide.
Hippocratic AI's core proposition is safety. The platform is built specifically for healthcare, where errors can carry serious consequences, and the company maintains dedicated safety, benchmarks, and research sections on its site. Its clinical research and LLM research programs suggest an ongoing effort to validate model behavior in medical contexts. The site also notes that patient call excerpts are de-identified in compliance with HIPAA, which matters for any organization handling protected health information.
Hippocratic AI has announced a next generation of healthcare AI built around orchestrators. The company frames this shift as moving from task-level automation to outcome-level coordination. Instead of completing isolated steps, orchestrators are designed to manage workflows toward a defined clinical or operational result. That distinction is important for healthcare organizations that need AI to support complex, multi-step processes rather than single interactions.
The platform includes a library of Skills that map to specific clinical and administrative workflows. Products include Polaris Pro and a range of AI agents organized by customer type. For providers, these include AI onboarding, leakage reduction, lost-to-follow-up, pharmacy, inpatient, ambulatory, readmission reduction, and STAR rating support. For payors, they include AI onboarding, pharmacy, chronic care management, rapid response, network management, STAR rating improvement, readmission prevention, and member retention. For life sciences, the catalog covers drug launch, sales coverage, sales coaching, adherence and persistence, access and reimbursement, medical affairs coverage, trial enrollment, trial retention, real-world evidence, and safety. Life sciences and med tech customers can also access AI product launch, sales expansion, sales enablement, patient activation, care companion, patient support, device trial enrollment, and post-market monitoring.
One concrete example is Annual Wellness Visit outreach and support. The platform identifies eligibility, schedules visits, performs intake, and addresses barriers such as social determinants of health that can limit patient access. This kind of workflow shows how the company applies voice AI to both administrative coordination and patient-facing communication.
Hippocratic AI maintains public benchmarks and research pages, including LLM Research and Clinical Research. These resources are intended to show how the company evaluates model performance and safety in clinical settings. For healthcare organizations, published benchmarks can be a useful starting point for due diligence, though they should be reviewed alongside internal validation and regulatory requirements.
The platform is aimed at organizations rather than individual clinicians or consumers. Health systems can use it to extend patient outreach and care management capacity. Payors can apply it to member onboarding, chronic care, and retention programs. Life sciences companies can use it across drug launch, adherence, trial enrollment, and post-market monitoring. The common thread is a need for safe, scalable voice AI that can handle sensitive healthcare conversations.
Hippocratic AI's breadth of use cases and its safety-first positioning make it a notable option in clinical voice AI. Organizations evaluating the platform should confirm which use cases are available for their specific deployment, review the company's benchmarks and research, and assess how the technology fits their compliance and regulatory obligations. Pricing and implementation details are not publicly listed, so interested teams should contact the company directly.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 14, 2026 →
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.
Microsoft for Healthcare brings Dragon Copilot, Dragon Medical One, and PowerMic Mobile to clinicians, combining speech recognition and an AI clinical assistant to streamline documentation and clinical tasks.
Notable is a healthcare automation platform that deploys AI agents across patient access, revenue cycle, care operations, and contact center work. It is built for health systems, health plans, and provider organizations that want to reduce administrative load without adding staff.
IQVIA provides life sciences organizations with data, analytics, and technology to accelerate innovation, improve patient outcomes, and bring treatments to market faster.